ArticleActa pharmaceutica Sinica. B2026
Enhanced tumor immunotherapy by nanovesicles derived from engineered DC-like M1 macrophage.
Linxia Jiang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it